United States Food & Drug Administration (USFDA) has completed a GMP inspection at Dr. Reddy’s Laboratories’ API Middleburgh facility in New York. The inspection was conducted from May 12, 2025 to May 16, 2025. The company has been issued a Form 483 with two observations, which it will address within the stipulated timeline.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1787.85 |
| Dr. Reddys Lab | 1268.00 |
| Cipla | 1380.40 |
| Zydus Lifesciences | 1098.05 |
| Lupin | 2254.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: